Switzerland· 65570006
Jardiance Met
A metformin and empagliflozin product containing empagliflozinum, metformini hydrochloridum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 13 of our 19 countries.
Checked against BAG Spezialitätenliste (Switzerland) on
Informational only — not a medical device.
Where it is registered
Metformin and empagliflozin is registered in 13 of 19 countries.
Countries holding a registration under ATC A10BD20 (metformin and empagliflozin), each read from that country’s own register.
- This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
- 8 of them publish a price we can compare per daily dose
Metformin and empagliflozin · ATC A10BD20
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
BAG Spezialitätenliste (Switzerland)- Active substance
- empagliflozinum, metformini hydrochloridum
- Manufacturer
- —
- Country
- Switzerland (CH)
- ATC code
- A10BD20
- ATC class
- Metformin and empagliflozin
- Swissmedic category
- B
- Reimbursed
- Yes
- Source register
- BAG Spezialitätenliste (Switzerland)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- gtin76806557000622x 90 StkCHF 157.7
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Metformin and empagliflozin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaMEMPOGLYNKrka, d.d., Novo mesto, Novo mesto
- IcelandApprefAdalvo Limited
- United StatesSynjardyBoehringer Ingelheim Pharmaceuticals, Inc.
- NetherlandsAppref 12,5 mg/1000 mg filmomhulde tablettenMeren Pharma B.V.
- IrelandEmpagliflozin/Metformin Krka 12.5 mg/1000 mg film-coated tabletsKRKA, d.d., Novo mesto
- United KingdomSynjardy 12.5mg/1000mg tabletsBoehringer Ingelheim Ltd
- CanadaSYNJARDYBOEHRINGER INGELHEIM (CANADA) LTD LTEE
- FinlandSynjardyBoehringer Ingelheim Pharma GmbH & Co. KG
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Empagliflozin/Metformin Hcs
- Belgium · Empagliflozine/Metformine Hcl Hcs
- Bulgaria · Empafel Met 5 Mg/850 Mg, Емпафел Мет
- Cyprus · Empagliflozin/Metformin Tad
- Czechia · Mempoglyn
- Denmark · Empagliflozin/Metformin Krka
- Estonia · Mempoglyn
- Spain · Empagliflozina/Metformina Krka
- Greece · Mempoglyn
- Croatia · Mempoglyn
- Hungary · Mempoglyn
- Ireland · Empagliflozin/Metformin Krka
- Iceland · Appref, Empagliflozin-Metformin Adalvo
- Liechtenstein · Synjardy
- Lithuania · Mempoglyn
- Luxembourg · Empagliflozin/Metformin Hcl Ab
- Latvia · Mempoglyn
- Malta · Appref, Empagliflozin-Metformin Adalvo
- Netherlands · Appref, Empagliflozine/Metformine Hcl Hcs
- Norway · Empagliflozin/Metformin Krka, Synjardy
- Portugal · Empagliflozina + Metformina Aurobindo, Empagliflozina + Metformina Generis
- Romania · Mempoglyn
- Slovenia · Emameten, Empagliflozin/Metformin Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/db08c253-972d-4002-95cb-489a2269bf10 GET /v1/drugs/db08c253-972d-4002-95cb-489a2269bf10?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unit": null,
"strength": "empagliflozinum 5 mg + metformini hydrochloridum 1000 mg",
"valid_from": "2016-01-01",
"limitations": "[{\"description\":\"<!DOCTYPE html>\\n<html>\\n<head></head>\\n<body>\\n<p>Zur Behandlung von Patienten mit einem Typ 2 Diabetes mellitus, welche zusätzlich zu diätetischen Massnahmen und körperlicher Aktivität keine adäquate Blutzuckerkontrolle erzielen und<br>- mit der maximal tolerierten Dosis Metformin oder<br>- mit der maximal tolerierten Dosis Metformin zusätzlich zu einem Sulfonylharnstoff und/oder einem Insulin behandelt werden und dabei keine adäquate Blutzuckerkontrolle erzielen oder<br>- in Kombination mit einem GLP1-1-Analogon oder<br>- bereits mit Empagliflozin und Metformin als separate Tabletten behandelt werden.<br>Es wird maximal eine Tagesdosierung von 10 mg Empagliflozin vergütet.</p>\\n</body>\\n</html>\",\"costApproval\":null,\"indication\":\"20401.01\",\"isNew\":true,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2026-09-01\",\"validTo\":null}]",
"galenic_form": "Filmtabl 5/1000mg",
"therapeutic_area": null,
"sl_inclusion_date": "2016-01-01",
"self_retention_pct": 10
}See everything about metformin and empagliflozin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.